Clinical trial
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
NCT03295162 is registered in ClinicalTrials.gov with Mohamed Hussein Metwally as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
- Lead sponsor
- Mohamed Hussein Metwally
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 26, 2015
- Completion date
- September 1, 2017
- Enrollment
- 55 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.